Strathclyde Institute for Medical DevicesWorking with us

Several technology opportunities are currently available for commercial exploitation with more being identified from the pre-commercial project portfolio in an on-going basis.

  • Effective delivery of drugs 
  • Transdermal patient monitoring
  • Bioreactor for production of engineered tissue
  • Optimal kinematics analysis for rehabilitation
  • Fitness performance wearable technology
  • Bilosomes:vechicles for oral delivery of drugs and vaccines
  • Computationally Optimised Design and Evaluation of Stents (CODE-S)
  • Intelligent Surgical Drill Systems
  • Predictive biomarkers for prostate cancer treatments
  • RNA-nanoprobes for early cancer diagnosis
  • Silk-based drup delivery systems
  • Ultra fast PCR technology